Skip to main content
Alan Moses, MD, Endocrinology, Plainsboro, NJ

Alan C Moses MD

Diabetes, Lipid Metabolism


Physician

Join to View Full Profile
  • Novo Nordisk Inc800 Scudders Mill RoadPlainsboro, NJ 08536

  • Phone+1 609-514-8099

Dr. Moses is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1979
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1974 - 1975
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1973

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1979 - 2025

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1990

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Virta Health Highlights Lasting, Transformative Health Improvements in 5-Year Diabetes Reversal Study
    Virta Health Highlights Lasting, Transformative Health Improvements in 5-Year Diabetes Reversal StudyJune 6th, 2022
  • BiomX Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
    BiomX Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateMarch 31st, 2021
  • BiomX : Appoints Paul Sekhri and Alan Moses, M.D., to Board of Directors
    BiomX : Appoints Paul Sekhri and Alan Moses, M.D., to Board of DirectorsOctober 5th, 2020
  • Join now to see all

Grant Support

  • Insulin &Insulin LIKE Growth Factor 1--Insulin ResistanNational Center For Research Resources2000–2002
  • Characterization Of Insulin &Insulin LIKE Growth Factor ResponsesNational Center For Research Resources1999–2002
  • Inhaled Human Insulin VS Usual Subcutaneous Insulin Therapy In IDDMNational Center For Research Resources1998–2002
  • Troglitazone In Moderate To Severe Insulin ResistanceNational Center For Research Resources1997–2002
  • Insulin And Insulinlike Growth Factor ResponsesNational Center For Research Resources1996–2002
  • Troglitazone With/Without Insulin For Insulin Requiring Patients With NIDDMNational Center For Research Resources1998–1999
  • Inhaled Human Insulin VS Usual SQ Human Insulin Therapy In NIDDMNational Center For Research Resources1998–1999
  • Biological Effect And Clinical Efficacy Of Octreotide, Analog Of SomatostatinNational Center For Research Resources1996–1999
  • Pilot Study Of A Novel, Noninvasive Method Of Blood Glucose MonitoringNational Center For Research Resources1997
  • Lyspro VS U-500 Insulin In Treatment Of Antibody Mediated Insulin ResistanceNational Center For Research Resources1997
  • General Clinical Research CenterNational Center For Research Resources1996–1997
  • Effect Of Lyspro VS U-500 Human Insulin In Treatment Of Antibody Mediated IRNational Center For Research Resources1996
  • Dose Finding Study Of RH IGF I In Type II DiabetesNational Center For Research Resources1996
  • Mechanism Underlying Local Insulin/Latex AllergyNational Center For Research Resources1995–1996
  • Characterization Of Insulin And Insulin-Like Growth Factor I ResponsesNational Center For Research Resources1995–1996
  • Recombinant Human IGF-I In The Treatment Of Type II Diabetes MellitusNational Center For Research Resources1995
  • Dose Finding Study Of Rhigh I In Type II DiabetesNational Center For Research Resources1995
  • Compassionate Use Of Growth Releasing HormoneNational Center For Research Resources1995

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: